论文信息 - Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer - 字舞流文

Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer

S. Tasaka | S. Takanashi | Y. Hasegawa | K. Okudera | Hisashi Tanaka | K. Taima | M. Itoga | H. Yasugahira | H. Nakagawa | H. Sakamoto | Keisuke Baba | Toshihiro Shiratori | Yoshiko Ishioka | Junichiro Tsuchiya